Anzeige
Mehr »
Login
Donnerstag, 03.10.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Citibank sagt $3.000 Gold voraus: Lernen Sie das Unternehmen kennen, das sich seit Jahren darauf vorbereitet
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
164 Leser
Artikel bewerten:
(1)

VSB - Technical University of Ostrava: Atomic Antibiotics Developed by Czech Scientists Counter Bacterial Resistance

OSTRAVA, Czech Republic, Oct. 3, 2024 /PRNewswire/ -- Scientists from Palacký University Olomouc (UP) and the Technical University of Ostrava (VSB-TUO), in collaboration with colleagues from China, have discovered a groundbreaking method for developing a new generation of antibiotics. These antibiotics not only combat a wide range of bacteria but also effectively prevent the development of bacterial resistance. By employing atomic engineering, the researchers transformed manganese-a trace element vital for human health-into a potent antibiotic by embedding it in the structure of chemically modified graphene. Tests conducted on animal models have demonstrated the material's significant potential, particularly in localized therapies such as wound healing. The discovery has been published in the prestigious journal Advanced Materials, and the team has filed a European patent to safeguard their innovation.

"The material we developed successfully kills and inhibits the growth of all bacteria we studied, including highly resistant pathogens. It operates at low concentrations, which are completely harmless to human cells. Furthermore, bacteria cannot develop resistance to it, thus addressing one of modern medicine's most pressing challenges. These promising results position atomic antibiotics for practical use in the near future," said Radek Zboril, a physical chemist and author of the research concept, who works at the Czech Advanced Technology and Research Institute (CATRIN UP) and the Centre for Energy and Environmental Technologies (CEET) at VSB-TUO.

A Frontal Attack with Manganese

In developing this antibiotic, the scientists drew on their expertise in graphene chemistry and atomic engineering, fields they have extensively studied in recent years. This time, they utilized a graphene derivative enriched with oxygen and nitrogen atoms, chemically incorporating manganese-a transition metal that is involved in metabolism, bone formation, blood sugar regulation and cellular protection against oxidative stress.

"We chose to target one of the strongest defences of bacteria-the carbohydrates in their cell walls and membranes, which are crucial for their survival. These carbohydrates play a protective role, facilitate substance transfer, enable communication with the environment, and serve as energy reserves. By chemically binding manganese to specific carbohydrate groups, we suppressed these critical functions, ultimately causing cell death. The graphene carrier plays an essential role by ensuring the delivery of manganese ions to the bacterial surface, which enables a direct chemical attack on the carbohydrate molecules," Zboril explained.

Effective Against Even the Most Resistant Bacteria

The new material also shows remarkable efficacy against bacteria that existing antibiotics struggle to combat. "We observed an excellent bactericidal effect against all bacteria from the ESCAPE group, which includes highly resistant bacterial pathogens. These bacteria are particularly dangerous because they are resistant to conventional antibiotics, which complicates treatment and increases the risk of severe infections, especially in hospital settings. The atomic antibiotic was the only agent that proved effective against all resistant bacteria, compared to commercial antibiotics," said David Panácek, the first author of the paper, from CATRIN UP and CEET VSB-TUO.

The researchers tested the atomic antibiotic's effect not only in laboratory settings but also in mouse models in collaboration with their Chinese colleagues. "In in-vivo tests, skin infections caused by resistant strains of Staphylococcus aureus (golden staph) healed quickly and effectively, with all markers of inflammation significantly reduced. We are now considering its use for wound dressings or antibacterial treatments on surfaces of artificial materials. There is tremendous potential to prevent bacterial biofilms from forming on devices such as artificial joint replacements, stents, or cannulas. Given its mode of action, this new material could also help prevent secondary infections, which would have a major impact on healthcare," said Milan Kolár, a microbiologist and Dean of the Faculty of Medicine and Dentistry at Palacký University Olomouc, who played a key role in the research.

Atomic Antibiotics Open New Possibilities

The research team plans to continue exploring the material's potential for systemic antibiotic treatments. "Some serious infections are now untreatable with existing antibiotics, and bacterial sepsis is becoming an increasingly common cause of death. We aim to test atomic antibiotics' effectiveness in treating the most severe bacterial diseases," Kolár added.

According to the United Nations, if bacterial resistance continues to rise at its current pace, by 2050 untreatable infections caused by multidrug-resistant bacteria could become the leading cause of death worldwide. These so-called 'superbugs' pose a global threat, necessitating the development of new antibacterial agents that can bypass the defence mechanisms bacteria use to protect themselves. This research, which also involved colleagues from the Faculty of Science at Palacký University Olomouc and two Chinese institutions, highlights the untapped potential of atomic engineering in addressing one of humanity's most urgent scientific and social challenges.

Read the paper at: Single Atom Engineered Antibiotics Overcome Bacterial Resistance - Panácek - Advanced Materials - Wiley Online Library

Cision View original content:https://www.prnewswire.co.uk/news-releases/atomic-antibiotics-developed-by-czech-scientists-counter-bacterial-resistance-302266579.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.